258 related articles for article (PubMed ID: 21544747)
1. Effects of dopamine and glutamate on synaptic plasticity: a computational modeling approach for drug abuse as comorbidity in mood disorders.
Qi Z; Kikuchi S; Tretter F; Voit EO
Pharmacopsychiatry; 2011 May; 44 Suppl 1():S62-75. PubMed ID: 21544747
[TBL] [Abstract][Full Text] [Related]
2. Synaptic plasticity and addiction: learning mechanisms gone awry.
Mameli M; Lüscher C
Neuropharmacology; 2011 Dec; 61(7):1052-9. PubMed ID: 21277315
[TBL] [Abstract][Full Text] [Related]
3. Synaptic plasticity in the mesolimbic dopamine system.
Thomas MJ; Malenka RC
Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):815-9. PubMed ID: 12740128
[TBL] [Abstract][Full Text] [Related]
4. Synaptic plasticity and addiction.
Kauer JA; Malenka RC
Nat Rev Neurosci; 2007 Nov; 8(11):844-58. PubMed ID: 17948030
[TBL] [Abstract][Full Text] [Related]
5. A novel mouse brain slice preparation of the hippocampo-accumbens pathway.
Matthews RT; Coker O; Winder DG
J Neurosci Methods; 2004 Aug; 137(1):49-60. PubMed ID: 15196826
[TBL] [Abstract][Full Text] [Related]
6. Repeated exposure to amphetamine disrupts dopaminergic modulation of excitatory synaptic plasticity and neurotransmission in nucleus accumbens.
Li Y; Kauer JA
Synapse; 2004 Jan; 51(1):1-10. PubMed ID: 14579420
[TBL] [Abstract][Full Text] [Related]
7. Neuroplastic alterations in the limbic system following cocaine or alcohol exposure.
Stuber GD; Hopf FW; Tye KM; Chen BT; Bonci A
Curr Top Behav Neurosci; 2010; 3():3-27. PubMed ID: 21161748
[TBL] [Abstract][Full Text] [Related]
8. Extracellular signal-regulated protein kinases 1 and 2 activation by addictive drugs: a signal toward pathological adaptation.
Pascoli V; Cahill E; Bellivier F; Caboche J; Vanhoutte P
Biol Psychiatry; 2014 Dec; 76(12):917-26. PubMed ID: 24844603
[TBL] [Abstract][Full Text] [Related]
9. Synaptic plasticity and drug addiction.
Jones S; Bonci A
Curr Opin Pharmacol; 2005 Feb; 5(1):20-5. PubMed ID: 15661621
[TBL] [Abstract][Full Text] [Related]
10. Psychomotor stimulants and neuronal plasticity.
Wolf ME; Sun X; Mangiavacchi S; Chao SZ
Neuropharmacology; 2004; 47 Suppl 1():61-79. PubMed ID: 15464126
[TBL] [Abstract][Full Text] [Related]
11. The neurobiology of slow synaptic transmission.
Greengard P
Science; 2001 Nov; 294(5544):1024-30. PubMed ID: 11691979
[TBL] [Abstract][Full Text] [Related]
12. Brief ischemia causes long-term depression in midbrain dopamine neurons.
Singh V; Carman M; Roeper J; Bonci A
Eur J Neurosci; 2007 Sep; 26(6):1489-99. PubMed ID: 17880389
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism.
Podda MV; Riccardi E; D'Ascenzo M; Azzena GB; Grassi C
Neuroscience; 2010 May; 167(3):678-90. PubMed ID: 20211700
[TBL] [Abstract][Full Text] [Related]
14. [Recent discoveries on the function and plasticity of central dopamine pathways].
Thibault D; Kortleven C; Fasano C; Dal Bo G; Trudeau LE
Med Sci (Paris); 2010 Feb; 26(2):165-70. PubMed ID: 20188048
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex.
Ninan I
J Neurochem; 2011 Oct; 119(2):324-31. PubMed ID: 21848811
[TBL] [Abstract][Full Text] [Related]
16. Dopamine and drug addiction: the nucleus accumbens shell connection.
Di Chiara G; Bassareo V; Fenu S; De Luca MA; Spina L; Cadoni C; Acquas E; Carboni E; Valentini V; Lecca D
Neuropharmacology; 2004; 47 Suppl 1():227-41. PubMed ID: 15464140
[TBL] [Abstract][Full Text] [Related]
17. Signaling in striatal neurons: the phosphoproteins of reward, addiction, and dyskinesia.
Girault JA
Prog Mol Biol Transl Sci; 2012; 106():33-62. PubMed ID: 22340713
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic Regulation of Striatal Interneurons in Reward and Addiction: Focus on Alcohol.
Clarke R; Adermark L
Neural Plast; 2015; 2015():814567. PubMed ID: 26246915
[TBL] [Abstract][Full Text] [Related]
19. ERK2: a logical AND gate critical for drug-induced plasticity?
Girault JA; Valjent E; Caboche J; Hervé D
Curr Opin Pharmacol; 2007 Feb; 7(1):77-85. PubMed ID: 17085074
[TBL] [Abstract][Full Text] [Related]
20. Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse.
Chen BT; Hopf FW; Bonci A
Ann N Y Acad Sci; 2010 Feb; 1187():129-39. PubMed ID: 20201850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
